Marchex Q1 revenue falls, adjusted EBITDA loss narrows
Marchex, Inc. Class B MCHX | 0.00 |
Overview
US AI conversation intelligence platform's Q1 revenue declined yr/yr
Adjusted EBITDA loss narrowed from prior year
Company expects Archenia acquisition to close in July 2026
Outlook
Marchex sees Q2 2026 revenue rising sequentially and Adjusted EBITDA of $1.6-$1.8 mln, above prior view
Company expects Q3 2026 revenue to rise sequentially and Adjusted EBITDA to reach $2 mln or more
If Archenia deal closes by Q3, combined Adjusted EBITDA could reach $2.5 mln for the quarter
Result Drivers
REORGANIZATION AND ACQUISITION COSTS - Adjusted EBITDA included $0.7 mln of reorganization and acquisition-related costs
AI PRODUCT DEPLOYMENT - Co said it continued developing and selling new AI-based products, with initial adoption among top customers
Company press release: ID:nBw7D250ha
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q1 Revenue |
Miss |
$10.62 mln |
$10.89 mln (1 Analyst) |
Q1 Adjusted EPS |
Miss |
-$0.03 |
$0 (1 Analyst) |
Q1 Net Income |
|
-$1.72 mln |
|
Q1 Adjusted EBITDA |
Miss |
-$147,000 |
$486,000 (1 Analyst) |
Q1 Income from Operations |
|
-$1.35 mln |
|
Q1 Operating Expenses |
|
$11.97 mln |
|
Analyst Coverage
The one available analyst rating on the shares is "buy"
The average consensus recommendation for the advertising & marketing peer group is "buy"
Wall Street's median 12-month price target for Marchex Inc is $4.00, about 151.6% above its May 12 closing price of $1.59
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.